Some clinical characteristics are fundamental for therapy decision, such as lymph node metastasis, hormone receptors status, human epidermal growth factor receptor 2 (HER2) expression and types of metastatic site [23]. The gene discussed is NR4A1; the disease is metastatic malignant neoplasm in the lymph nodes.